Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.

IF 37.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
David Ferreira, Jack Hardy, William Meere, Lloyd Butel-Simoes, Shanathan Sritharan, Max Ray, Matthew French, Michael McGee, Simon O'Connor, Nicholas Whitehead, Stuart Turner, Paul Healey, Allan Davies, Gwilym Morris, Nicholas Jackson, Malcolm Barlow, Tom Ford, Sarah Leask, Christopher Oldmeadow, John Attia, Aaron Sverdlov, Nicholas Collins, Andrew Boyle, Bradley Wilsmore
{"title":"Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.","authors":"David Ferreira, Jack Hardy, William Meere, Lloyd Butel-Simoes, Shanathan Sritharan, Max Ray, Matthew French, Michael McGee, Simon O'Connor, Nicholas Whitehead, Stuart Turner, Paul Healey, Allan Davies, Gwilym Morris, Nicholas Jackson, Malcolm Barlow, Tom Ford, Sarah Leask, Christopher Oldmeadow, John Attia, Aaron Sverdlov, Nicholas Collins, Andrew Boyle, Bradley Wilsmore","doi":"10.1093/eurheartj/ehae573","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Current guidelines recommend 6 h of solid food and 2 h of clear liquid fasting for patients undergoing cardiac procedures with conscious sedation. There are no data to support this practice, and previous single-centre studies support the safety of removing fasting requirements. The objective of this study was to determine the non-inferiority of a no-fasting strategy to fasting prior to cardiac catheterization procedures which require conscious sedation.</p><p><strong>Methods: </strong>This is a multicentre, investigator-initiated, non-inferiority, randomized trial conducted in Australia with a prospective open-label, blinded endpoint design. Patients referred for coronary angiography, percutaneous coronary intervention, or cardiac implantable electronic device (CIED)-related procedures were enrolled. Patients were randomized 1:1 to fasting as normal (6 h solid food and 2 h clear liquid) or no-fasting requirements (encouraged to have regular meals but not mandated to do so). Recruitment occurred from 2022 to 2023. The primary outcome was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia assessed with a Bayesian approach. Secondary outcomes included patient satisfaction score, new ventilation requirement (non-invasive and invasive), new intensive care unit admission, 30-day readmission, 30-day mortality, 30-day pneumonia.</p><p><strong>Results: </strong>A total of 716 patients were randomized with 358 in each group. Those in the fasting arm had significantly longer solid food fasting (13.2 vs. 3.0 h, Bayes factor >100, indicating extreme evidence of difference) and clear liquid fasting times (7.0 vs. 2.4 h, Bayes factor >100). The primary composite outcome occurred in 19.1% of patients in the fasting arm and 12.0% of patients in the no-fasting arm. The estimate of the mean posterior difference in proportions with credibility interval (CI) in the primary composite outcome was -5.2% (95% CI -9.6 to -.9), favouring no fasting. This result confirms the non-inferiority (posterior probability >99.5%) and superiority (posterior probability 99.1%) of no fasting for the primary composite outcome. The no-fasting arm had improved patient satisfaction scores with a posterior mean difference of 4.02 points (95% CI 3.36-4.67, Bayes factor >100). Secondary outcome events were observed to be similar.</p><p><strong>Conclusions: </strong>In patients undergoing cardiac catheterization and CIED-related procedures, no fasting was non-inferior and superior to fasting for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Patient satisfaction scores were significantly better with no fasting. This supports removing fasting requirements for patients undergoing cardiac catheterization laboratory procedures that require conscious sedation.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"4990-4998"},"PeriodicalIF":37.6000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehae573","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Current guidelines recommend 6 h of solid food and 2 h of clear liquid fasting for patients undergoing cardiac procedures with conscious sedation. There are no data to support this practice, and previous single-centre studies support the safety of removing fasting requirements. The objective of this study was to determine the non-inferiority of a no-fasting strategy to fasting prior to cardiac catheterization procedures which require conscious sedation.

Methods: This is a multicentre, investigator-initiated, non-inferiority, randomized trial conducted in Australia with a prospective open-label, blinded endpoint design. Patients referred for coronary angiography, percutaneous coronary intervention, or cardiac implantable electronic device (CIED)-related procedures were enrolled. Patients were randomized 1:1 to fasting as normal (6 h solid food and 2 h clear liquid) or no-fasting requirements (encouraged to have regular meals but not mandated to do so). Recruitment occurred from 2022 to 2023. The primary outcome was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia assessed with a Bayesian approach. Secondary outcomes included patient satisfaction score, new ventilation requirement (non-invasive and invasive), new intensive care unit admission, 30-day readmission, 30-day mortality, 30-day pneumonia.

Results: A total of 716 patients were randomized with 358 in each group. Those in the fasting arm had significantly longer solid food fasting (13.2 vs. 3.0 h, Bayes factor >100, indicating extreme evidence of difference) and clear liquid fasting times (7.0 vs. 2.4 h, Bayes factor >100). The primary composite outcome occurred in 19.1% of patients in the fasting arm and 12.0% of patients in the no-fasting arm. The estimate of the mean posterior difference in proportions with credibility interval (CI) in the primary composite outcome was -5.2% (95% CI -9.6 to -.9), favouring no fasting. This result confirms the non-inferiority (posterior probability >99.5%) and superiority (posterior probability 99.1%) of no fasting for the primary composite outcome. The no-fasting arm had improved patient satisfaction scores with a posterior mean difference of 4.02 points (95% CI 3.36-4.67, Bayes factor >100). Secondary outcome events were observed to be similar.

Conclusions: In patients undergoing cardiac catheterization and CIED-related procedures, no fasting was non-inferior and superior to fasting for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Patient satisfaction scores were significantly better with no fasting. This supports removing fasting requirements for patients undergoing cardiac catheterization laboratory procedures that require conscious sedation.

导管室手术前禁食与不禁食:SCOFF 试验。
背景和目的:现行指南建议在有意识镇静的情况下接受心脏手术的患者禁食 6 小时固体食物和 2 小时透明液体。目前还没有数据支持这种做法,之前的单中心研究也支持取消禁食要求的安全性。本研究的目的是确定在需要有意识镇静的心导管手术前不禁食策略与禁食策略的非劣效性:这是一项由研究者发起的多中心非劣效性随机试验,在澳大利亚进行,采用前瞻性开放标签盲法终点设计。接受冠状动脉造影术、经皮冠状动脉介入治疗或心脏植入电子装置(CIED)相关手术的患者均被纳入试验范围。患者按1:1的比例被随机分配到正常禁食(6小时固体食物和2小时透明液体)或无禁食要求(鼓励定时进餐,但不强制)。招募时间为 2022 年至 2023 年。主要结果是吸入性肺炎、低血压、高血糖和低血糖的复合结果,采用贝叶斯方法进行评估。次要结果包括患者满意度评分、新通气需求(无创和有创)、新入住重症监护病房、30 天再入院、30 天死亡率、30 天肺炎:716 名患者接受了随机治疗,每组 358 人。禁食组患者禁食固体食物的时间明显更长(13.2 小时对 3.0 小时,贝叶斯因子大于 100,表明存在极度差异),禁食透明液体的时间也明显更长(7.0 小时对 2.4 小时,贝叶斯因子大于 100)。19.1%的禁食组患者和12.0%的非禁食组患者出现了主要复合结果。主要综合结果的平均比例后差异估计值为-5.2%(95% CI -9.6至-0.9,),不禁食组更胜一筹。这一结果证实了不禁食疗法在主要综合结果方面的非劣效性(后验概率>99.5%)和优越性(后验概率99.1%)。不禁食治疗组的患者满意度评分有所提高,后验均差为 4.02 分(95% CI 3.36 至 4.67,贝叶斯因子大于 100)。次要结果事件相似:结论:对于接受心导管检查和 CIED 相关手术的患者,在吸入性肺炎、低血压、高血糖和低血糖的主要综合结果方面,不禁食并不劣于禁食。不禁食的患者满意度评分明显更高。这支持对接受心导管实验室手术、需要有意识镇静的患者取消禁食要求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Heart Journal
European Heart Journal 医学-心血管系统
CiteScore
39.30
自引率
6.90%
发文量
3942
审稿时长
1 months
期刊介绍: The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信